FDA official logo
GSRS logo
PFDA official logo

PRORENOATE POTASSIUM

  • UNII: T2D4XUS623
  • Formula: C23H31O4.K
  • Preferred Substance Name: PRORENOATE POTASSIUM
  • InChIKey: NLSAMWIBIQWHTK-CZKUEYQYSA-M

  • 49847-97-4
  • 3'H-CYCLOPROPA(6,7)PREGNA-4,6-DIENE-21-CARBOXYLIC ACID, 6,7-DIHYDRO-17-HYDROXY-3-OXO-, (6.ALPHA.,7.ALPHA.,17.ALPHA.)-, MONOPOTASSIUM SALT
  • 3'H-CYCLOPROPA(6,7)PREGNA-4,6-DIENE-21-CARBOXYLIC ACID, 6,7-DIHYDRO-17-HYDROXY-3-OXO-, MONOPOTASSIUM SALT, (6-.ALPHA.,7-.ALPHA.,17-.ALPHA.)-
  • PRORENOATE POTASSIUM [INN]
  • PRORENOATE POTASSIUM [USAN]
  • SC 23992
  • SC-23992

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.